Thomas Jefferson University
News Articles

Need to Analyze Your Next-Generation Sequencing Data? Thomas Jefferson University’s New Web-Based Resource Makes the Task Easy
  In the early 1990s, an international effort was launched by the U.S. Department of Energy and the National Institutes of Health to sequence the human genome. The project took 13 years,...

Weekend Workshops in Biotechnology Start June 29
Faculty from the Department of Bioscience Technologies at Thomas Jefferson University’s Jefferson School of Health Professions are offering Weekend Workshops in Biotechnology starting June 29...

Thomas Jefferson University Holds Commencement for Class of 2013
  PHILADELPHIA— Thomas Jefferson University will hold its 189th Annual Commencement to graduate students from Jefferson Medical College, Jefferson Graduate School of Biomedical Sciences...

Berkowitz Family Foundation Funds Lecture Highlighting Humanism in Medicine
Thomas Jefferson University has received a generous gift from Mr. Edwin Berkowitz and The Berkowitz Family Foundation of Merion, PA to fund an annual program on humanism in medicine that will attract...

Takami Sato, M.D., Named Endowed Professor of Medical Oncology in Honor of Distinguished Japanese Physicians
Internationally-recognized cancer clinician and researcher Takami Sato, M.D., Ph.D., who serves as the Director of the Metastatic Uveal Melanoma Program in the Department of Medical Oncology at Thomas...

Improving Prostate Cancer Outcomes in Ghana Could Take More Screenings, Tailored Treatments—and Breaking Down the Stigma
 Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country’s most threatening epidemic: cancer. A new study published in January...

Phone and Mailed Interventions Significantly Increase Colorectal Cancer Screening Rates
A mailing or phone call to help patients get screened for colorectal cancer significantly increases their chances of actually getting tested, according to a study published in the January issue of...

Medication Errors in the Elderly Are Costing at Least $4.2 Billion Annually: Jefferson’s Proof-of-Concept Study Points to a Solution
Researchers at the Jefferson School of Population Health, working with colleagues at the Parma Local Health Authority in Italy, significantly reduced the prescribing of dangerous medications for older...

Bench to Bedside: How to Fast Track Targeted Cancer Drugs with Radiation into the Clinic
Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical...

Researchers at Jefferson’s Kimmel Cancer Center Discover New Pathways that Drive Metastatic Prostate Cancer
 Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December...

Game Changing Diagnostic and Prognostic Prostate Cancer Genetic Tests Revealed by Jefferson’s Kimmel Cancer Center
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes...

Promising Drug Slows Down Advance of Parkinson’s Disease and Improves Symptoms
 Treating Parkinson’s disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson...

Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize
Thomas Jefferson University will honor the renowned biotech researcher whose discoveries led to a slew of innovative drugs that revolutionized treatment including Herceptin—one of the first...

New Tumor Tracking Technique May Improve Outcomes for Lung Cancer Patients
Medical physicists at Thomas Jefferson University and Jefferson’s Kimmel Cancer Center are one step closer to bringing a new tumor-tracking technique into the clinic that delivers higher levels...

NCI Awards ‘Provocative Questions’ Grant to Thomas Jefferson University Researcher Scott Waldman
Scott Waldman, M.D., Ph.D., chairman of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded one of the prestigious “Provocative...

Thomas Jefferson University Awarded NIH Grant to Study Fibrotic Skin Disease Caused by MRI Contrast Agents
Researchers at the Jefferson Institute of Molecular Medicine were awarded almost $384,000 by the National Institutes of Health to investigate the mechanisms involved in the development of a serious...

Doubling up on Advanced Prostate Cancer with PARP-1 Inhibitors
A newly-discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent, preclinical study published in Cancer Discovery by...

Stat5 Predicts Outcomes for Prostate Cancer Patients after Radical Prostatectomy
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had...

Loss of Protective Heart Failure Protein Linked to Critical Limb Ischemia
Restoring diminished levels of a protein shown to prevent and reverse heart failure damage could also have therapeutic applications for patients with critical limb ischemia (CLI), suggests a new...

Recovering ‘Bodyguard’ Cells in Pancreas May Restore Insulin Production in Diabetics
The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the...

1st Annual Diabetes Symposium: New Advances and Innovations Draws Industry Leaders to Thomas Jefferson University Hospital
1st Annual Diabetes Symposium: New Advances and Innovations Draws Industry Leaders to Thomas Jefferson University Hospital   (PHILADELPHIA) – Key national and international players on the...

Large Study of Italian Diabetic Patients Confirms Physician's Empathy Directly Associated with Positive Clinical Outcomes
Patients of doctors who are more empathic have better outcomes and fewer complications, concludes a large, empirical study by a team of Thomas Jefferson University and Italian researchers who...

Jefferson School of Pharmacy Faculty Member Gerald Meyer Elected ASHP President
Gerald Meyer, MBA, PharmD, FASHP, Director of Experiential Education at the Jefferson School of Pharmacy, Thomas Jefferson University, was elected president-elect of the American Society of...

Histone Modifying Proteins, Not Histones, Remain Associated with DNA through Replication, Say Epigenetic Researchers
PHILADELPHIA—It’s widely accepted that molecular mechanisms mediating epigenetics include DNA methylation and histone modifications, but a team from Thomas Jefferson University has...

Thomas Jefferson University Renames its Graduate School
PHILADELPHIA—The Jefferson College of Graduate Studies has been renamed the Jefferson Graduate School of Biomedical Sciences (JGSBS) to better reflect the school’s breadth of degrees and...

Breast Cancer Patients Who Lack RB Gene Respond Better to Neoadjuvant Chemotherapy
Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University...

Jefferson School of Pharmacy’s Doctor of Pharmacy Program Receives Accreditation
The Doctor of Pharmacy program offered by Jefferson School of Pharmacy of Thomas Jefferson University has been accredited by the Accreditation Council for Pharmacy Education. “Congratulations...

ATP: From Bystander to Actor in Kinase Regulation
A new function of ATP—beyond its passive roles as an energy source and a phosphate donor for phosphorylation reactions—was unraveled by Jefferson researchers.   Their studies...

HIV Drug May Slow Down Metastatic Breast Cancer, Researchers at Jefferson’s Kimmel Cancer Center Report
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study...

Japan Center Established
In January 2012 the Japan Center for Health Professions Education and Research at Jefferson was established between Thomas Jefferson University, and the Japanese Association for the Development of...

Jefferson’s Kimmel Cancer Center to Host Tribute Dinner Honoring Steve Sabol, President of NFL Films
PHILADELPHIA—Jefferson’s Kimmel Cancer Center will host a tribute dinner to honor legendary filmmaker Steve Sabol, President of NFL Films, with the Spirit of Courage Award at the Union...

A Closer Look at PARP-1 Reveals Potential New Drug Targets
A new study published in Science May 11 is shedding light on the molecular details of PARP-1, a DNA damage-detecting enzyme that when inhibited has been shown to be effective in fighting cancer and...

Jefferson Receives $2.6 Million NIH Grant to Study Imaging Method to Stage Prostate Cancer Without Biopsy
Jefferson’s Kimmel Cancer Center and the Department of Radiology at Thomas Jefferson University received a five-year, $2.6 million grant from the National Institutes of Health (NIH) to...

Nanobiotix and Thomas Jefferson University Start Research Collaboration
Paris, France and Philadelphia, USA – May 2, 2012 - Nanobiotix, a company developing novel cancer nanotherapeutics and Thomas Jefferson University, one of Philadelphia's premier medical and...

Poorer Quality of Life for Certain Subpopulations After Prostate Cancer Treatment: What Are We Missing?
PHILADELPHIA— To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men...

Jefferson’s Scott Waldman, M.D., Ph.D., Awarded CURE Grant to Move Colon Cancer Test Closer to Commercialization
Scott Waldman, M.D., Ph.D., Chair of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded a Commonwealth Universal Research Enhancement (CURE)...

Richard C. Gozon Named Interim President of Thomas Jefferson University
Richard C. Gozon has been appointed Interim President of Thomas Jefferson University (TJU), beginning July 1, 2012 and ending June 30, 2013, announced David R. Binswanger, TJU Board Chairman. A...

Rawls Palmer Progress in Medicine Award Presented to Dr. Scott A. Waldman
Scott A. Waldman, M.D., Ph.D., will receive the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Rawls–Palmer Progress in Medicine Award at the 2012 Annual Meeting on March...

Jefferson Researcher Finds Empathy Difficult for Medical Students to Maintain; Creates Model to Improve and Sustain Students' Empathy
Philadelphia, PA — One year ago, a landmark study led by Mohammadreza Hojat, Ph.D., research professor, Department of Psychiatry and Human Behavior at Thomas Jefferson University, quantified a...

Jefferson Appoints Assistant Dean for Clinical Research
Jefferson Appoints Assistant Dean for Clinical Research ...

Stronger Intestinal Barrier May Prevent Cancer in the Rest of the Body, New Study Suggests
Philadelphia, PA — A leaky gut may be the root of some cancers forming in the rest of the body, a new study published online Feb. 21 in PLoS ONE by Thomas Jefferson University researchers...

Thomas Jefferson University's Takemi Tanaka, Ph.D, Awarded 'Refunds for Research' Grant
Philadelphia, PA — Takemi Tanaka, Ph.D., of Thomas Jefferson University’s School of Pharmacy and the Kimmel Cancer Center, received a $50,000 grant toward her breast cancer research, as...

Thomas Jefferson University Opens Health Professions Academic Building at 901 Walnut Street
Philadelphia, PA — Thomas Jefferson University will welcome trustees, donors, deans, department chairs, and its neighbors to a special ribbon-cutting ceremony on Wednesday, February 15, at...

Drugs Targeting Chromosomal Instability May Fight a Particular Breast Cancer Subtype
Philadelphia, PA — Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson’s Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD.,...

Jefferson Researchers Mirror Human Response to Bacterial Infection and Resolution in Mice
Philadelphia, PA —Imitating human diseases using an animal model is a difficult task, but Thomas Jefferson University researchers have managed to come very close. Reporting in the Proceedings...

Thomas Jefferson University Receives Science Center's QED Award for Pancreatic Cancer Research
Philadelphia, PA — Hwyda Arafat, M.D., Ph.D., Associate Professor of Surgery at Thomas Jefferson University and co-director of the Jefferson Pancreatic, Biliary and Related Cancers Center,...

Dr. Bo Lu to Lead the Radiation Therapy Oncology Group's Lung Cancer Translational Research Program
Philadelphia, PA —The Radiation Therapy Oncology Group (RTOG) announced that Bo Lu, M.D., Ph.D., of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has been...

Jefferson's Department of Psychiatry Receives Three-Year Suicide Prevention Grants
Philadelphia, PA — Through a grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) that was given to the Commonwealth of Pennsylvania, Thomas Jefferson University ...

Kimmel Cancer Center at Jefferson Pinpoints a New "Achilles' Heel" in Breast Cancer: Tumor Cell Mitochondria
Philadelphia, PA — Researchers at the Kimmel Cancer Center at Jefferson have identified cancer cell mitochondria as the unsuspecting powerhouse and “Achilles’ heel” of tumor...

Dean of Jefferson School of Population Health Honored by America-Israel Chamber of Commerce
Philadelphia, PA — Dr. David Nash, dean of Jefferson School of Population Health, Thomas Jefferson University, was recently honored by the America-Israel Chamber of Commerce (AICC) as one of...

Nuclear Receptors Battle it Out During Metamorphosis in New Fruit Fly Model
Nuclear Receptors Battle it Out During Metamorphosis in New Fruit Fly Model...

Jefferson School of Nursing Receives $1 Million Grant for Online Graduate Programs in Rural Underserved Communities
Jefferson School of Nursing Receives $1 Million Grant for Online Graduate Programs in Rural Underserved Communities...

Robert L. Barchi, M.D., Ph.D., to Step Down as President of Thomas Jefferson University
Robert L. Barchi, M.D., Ph.D., to Step Down as President of Thomas Jefferson University ...


Click to leave feedback
feedback